The Manufacturers Life Insurance Company lowered its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 18.4% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 236,680 shares of the medical instruments supplier’s stock after selling 53,430 shares during the period. The Manufacturers Life Insurance Company owned about 0.10% of DENTSPLY SIRONA worth $15,347,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently modified their holdings of the business. York Capital Management Global Advisors LLC bought a new stake in DENTSPLY SIRONA during the second quarter worth about $17,953,000. Gotham Asset Management LLC bought a new stake in DENTSPLY SIRONA during the second quarter worth about $5,111,000. Cramer Rosenthal Mcglynn LLC lifted its stake in DENTSPLY SIRONA by 4.3% during the second quarter. Cramer Rosenthal Mcglynn LLC now owns 675,165 shares of the medical instruments supplier’s stock worth $43,778,000 after purchasing an additional 27,770 shares during the last quarter. AHL Partners LLP lifted its stake in DENTSPLY SIRONA by 20.6% during the second quarter. AHL Partners LLP now owns 162,709 shares of the medical instruments supplier’s stock worth $10,550,000 after purchasing an additional 27,747 shares during the last quarter. Finally, Sun Life Financial INC lifted its stake in DENTSPLY SIRONA by 63,362.5% during the second quarter. Sun Life Financial INC now owns 5,077 shares of the medical instruments supplier’s stock worth $330,000 after purchasing an additional 5,069 shares during the last quarter. 93.87% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “DENTSPLY SIRONA Inc. (XRAY) Shares Sold by The Manufacturers Life Insurance Company” was originally published by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at https://www.dailypolitical.com/2017/10/19/dentsply-sirona-inc-xray-shares-sold-by-the-manufacturers-life-insurance-company.html.

DENTSPLY SIRONA Inc. (NASDAQ XRAY) opened at 59.50 on Thursday. The firm’s 50 day moving average price is $58.21 and its 200-day moving average price is $61.01. The stock’s market cap is $13.66 billion. DENTSPLY SIRONA Inc. has a 12-month low of $52.54 and a 12-month high of $65.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings data on Wednesday, August 9th. The medical instruments supplier reported $0.65 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.65. The business had revenue of $992.70 million during the quarter, compared to the consensus estimate of $1 billion. DENTSPLY SIRONA had a negative net margin of 20.57% and a positive return on equity of 7.24%. The firm’s quarterly revenue was down 2.9% compared to the same quarter last year. During the same quarter last year, the firm earned $0.76 earnings per share. Equities research analysts anticipate that DENTSPLY SIRONA Inc. will post $2.68 earnings per share for the current fiscal year.

XRAY has been the subject of several research analyst reports. UBS AG reaffirmed a “neutral” rating and set a $59.00 price target (down previously from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. BidaskClub lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Friday, July 28th. Jefferies Group LLC dropped their price target on DENTSPLY SIRONA from $72.00 to $66.00 and set a “buy” rating for the company in a research note on Wednesday, August 23rd. Cleveland Research lowered DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a research note on Thursday, October 5th. Finally, Zacks Investment Research lowered DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research note on Monday, August 14th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $65.89.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.